1. Home
  2. DFTX vs FCN Comparison

DFTX vs FCN Comparison

Compare DFTX & FCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Definium Therapeutics Inc. Common Shares

DFTX

Definium Therapeutics Inc. Common Shares

SELL

Current Price

$30.21

Market Cap

5.9B

Sector

N/A

ML Signal

SELL

Logo FTI Consulting Inc.

FCN

FTI Consulting Inc.

SELL

Current Price

$206.37

Market Cap

5.4B

ML Signal

SELL

Company Overview

Basic Information
Metric
DFTX
FCN
Founded
N/A
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.9B
5.4B
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
DFTX
FCN
Price
$30.21
$206.37
Analyst Decision
Strong Buy
Buy
Analyst Count
19
3
Target Price
$72.83
★ $186.50
AVG Volume (30 Days)
★ 1.5M
433.7K
Earning Date
11-09-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 5.51
EPS
N/A
★ 6.22
Revenue
N/A
★ $3,788,857,000.00
Revenue This Year
N/A
$5.49
Revenue Next Year
N/A
$4.89
P/E Ratio
★ N/A
$33.20
Revenue Growth
N/A
★ 2.44
52 Week Low
$14.62
$129.12
52 Week High
$49.70
$208.70

Technical Indicators

Market Signals
Indicator
DFTX
FCN
Relative Strength Index (RSI) 37.55 83.50
Support Level $20.43 $151.05
Resistance Level $38.59 N/A
Average True Range (ATR) 2.10 7.16
MACD -0.21 1.34
Stochastic Oscillator 3.34 96.75

Price Performance

Historical Comparison
DFTX
FCN

About DFTX Definium Therapeutics Inc. Common Shares

Definium Therapeutics Inc is developing inventive, next-generation therapeutics intended to solve the underlying causes of psychiatric and neurological disorders and offer patients long-term remission rather than transient symptom reduction. Its late-stage pipeline includes four Phase 3 trials-two each for GAD and MDD-anchored by its candidate, DT120 ODT, which has received FDA Breakthrough Therapy Designation for GAD. In parallel, the Company is advancing its commercial and operational readiness to support a care model and prepare for the potential launch of DT120 ODT, if approved and marketed. The company operates in one reportable segment relating to the research and development of the company's neurological drug development platform.

About FCN FTI Consulting Inc.

FTI Consulting Inc is a firm that generates its sales by providing professional business advisory services to customers. The company operates through five segments, namely corporate finance, forensic and litigation consulting, economic consulting, technology, and strategic communications. The company generates the majority of its revenue from the Corporate finance segment. Customers of the company come from a wide array of sectors, including construction, energy and power, environmental, financial institutions, healthcare and life science, insurance, real estate and infrastructure, retail and consumer products, telecom, media, and technology. The majority of the company's revenue is derived from serving customers in the United States.

Share on Social Networks: